I have gotten a few questions on $SNPX and figured I would take the time to go thru some history to explain the optimism on the 4Q read out. First, the company failed two phase II trials a couple years back. Why? Trial design. Remember Alzheimer’s has had no approved drugs to reduce the decline of cognitive effects let alone what $SNPX Bryostatin 1 …
© 2024 Fein Luxe LLC
Substack is the home for great culture